Disease Info Card

Hepatic Veno-occlusive Disease

Information about Hepatic Veno-occlusive Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hepatic Veno-occlusive Disease

Most recent studies have shown that Hepatic Veno-occlusive Disease shares some biological mechanisms with acute-gvh-disease, budd-chiari-syndrome, fibrosis, graft-vs-host-disease, hematologic-neoplasms, hemorrhage, hepatomegaly, hypertension-portal, hypertensive-disease, icterus, leukemia, leukemia-myelocytic-acute, liver-diseases, liver-failure, malignant-neoplasms, myeloid-leukemia, neoplasms, pneumonia, thrombosis, venoocclusive-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hepatic Veno-occlusive Disease, and have been seen in publications frequently: Cell Activation, Cell Adhesion, Cell Death, Coagulation, Conjugation, Cytokine Production, Cytolysis, Diuresis, Endothelial Cell Activation, Fibrinolysis, Glomerular Filtration, Hemostasis, Immune Response, Inflammatory Response, Liver Regeneration, Localization, Pathogenesis, Regeneration, Urea Cycle, Vasoconstriction

Quite a number of genes have been found to play important roles in Hepatic Veno-occlusive Disease, such as ALB, ASXL1, BCHE, BCR, CD33, CELA3B, CFD, F2, F3, IL6, PLAT, PLG, SERPINC1, SERPINE1, THBD, TNF, VWF, YWHAE. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.